Please assess the completion status of the following clinical trial:

Trial Title: Statins and Endothelial Function in Patients With Coarctation of the Aorta

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients over the age of 18 years with repaired coarctation of the aorta (CoA) and willing to participate in all portions of the study including follow up, blood draws, urine sample, echocardiogram, MRI, brachial artery flow-mediated dilatation (FMD) testing, Carotid Intima Media Thickness (CIMT) testing and statin administration.~Exclusion Criteria:~* patients who are pregnant, nursing, or planning on becoming pregnant in the subsequent year~* current smokers~* patients with documented coronary artery disease (CAD), other systemic inflammatory disorder such as systemic lupus erythematosis or rheumatoid arthritis~* patients already on statin therapy or who have had previous adverse effects to statin therapy~* patients with hepatic transaminases \>2X the upper limit of normal~* patients with creatinine clearance \<60mg/dL~* patients who have implanted devices such as pacemakers or defibrillators that preclude MRI testing~* patients with low blood pressure at baseline (\< 90/50)~* patients who are unwilling or unable to comply with the aforementioned portions of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- atorvastatin (Type: EXPERIMENTAL): Patients are randomized to either atorvastatin or placebo once daily for 12 weeks. There is a 4 week washout, and then the groups are switched for 12 weeks. Brachial artery assessment will be performed before and after each 12 week period on therapy.
- sugar pill (Type: PLACEBO_COMPARATOR): See above. Patients will be randomized to atorvastatin vs. placebo for 12 weeks and after a 4 week washout period the groups will be switched.

Based on this trial design, predict the completion outcome and termination type (if applicable).